Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Nucleic Acid Labeling Market, By Product Type
7.1. Nucleic Acid Labeling Market, By Product Type, 2020-2030
7.1.1. Kits
7.1.1.1. Market Revenue and Forecast (2016-2030)
7.1.2. Reagents
7.1.2.1. Market Revenue and Forecast (2016-2030)
7.1.3. Instruments
7.1.3.1. Market Revenue and Forecast (2016-2030)
Chapter 8. Global Nucleic Acid Labeling Market, By Labeling Type
8.1. Nucleic Acid Labeling Market, By Labeling Type, 2020-2030
8.1.1. Radioisotope/Radioactive Labels
8.1.1.1. Market Revenue and Forecast (2016-2030)
8.1.2. Non-radioactive Labels
8.1.2.1. Market Revenue and Forecast (2016-2030)
Chapter 9. Global Nucleic Acid Labeling Market, By Method Type
9.1. Nucleic Acid Labeling Market, By Method Type, 2020-2030
9.1.1. Enzyme-based
9.1.1.1. Market Revenue and Forecast (2016-2030)
9.1.2. Chemical-based
9.1.2.1. Market Revenue and Forecast (2016-2030)
Chapter 10. Global Nucleic Acid Labeling Market, By Application Type
10.1. Nucleic Acid Labeling Market, By Application Type, 2020-2030
10.1.1. Oligonucleotide Labeling
10.1.1.1. Market Revenue and Forecast (2016-2030)
10.1.2. In-situ Hybridization
10.1.2.1. Market Revenue and Forecast (2016-2030)
10.1.3. Southern & Northern Blotting
10.1.3.1. Market Revenue and Forecast (2016-2030)
10.1.4. Cellular Localization
10.1.4.1. Market Revenue and Forecast (2016-2030)
10.1.5. Others
10.1.5.1. Market Revenue and Forecast (2016-2030)
Chapter 11. Global Nucleic Acid Labeling Market, By Sector Type
11.1. Nucleic Acid Labeling Market, By Sector, 2020-2030
11.1.1. Diagnostics
11.1.1.1. Market Revenue and Forecast (2016-2030)
11.1.2. Research
11.1.2.1. Market Revenue and Forecast (2016-2030)
11.1.3. Therapeutics
11.1.3.1. Market Revenue and Forecast (2016-2030)
Chapter 12. Global Nucleic Acid Labeling Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, By Product Type (2016-2030)
12.1.2. Market Revenue and Forecast, By Labeling Type (2016-2030)
12.1.3. Market Revenue and Forecast, By Method (2016-2030)
12.1.4. Market Revenue and Forecast, By Application (2016-2030)
12.1.5. Market Revenue and Forecast, By Sector (2016-2030)
12.1.6. U.S.
12.1.6.1. Market Revenue and Forecast, By Product Type (2016-2030)
12.1.6.2. Market Revenue and Forecast, By Labeling Type (2016-2030)
12.1.6.3. Market Revenue and Forecast, By Method (2016-2030)
12.1.6.4. Market Revenue and Forecast, By Application (2016-2030)
12.1.7. Market Revenue and Forecast, By Sector (2016-2030)
12.1.8. Rest of North America
12.1.8.1. Market Revenue and Forecast, By Product Type (2016-2030)
12.1.8.2. Market Revenue and Forecast, By Labeling Type (2016-2030)
12.1.8.3. Market Revenue and Forecast, By Method (2016-2030)
12.1.8.4. Market Revenue and Forecast, By Application (2016-2030)
12.1.8.5. Market Revenue and Forecast, By Sector (2016-2030)
12.2. Europe
12.2.1. Market Revenue and Forecast, By Product Type (2016-2030)
12.2.2. Market Revenue and Forecast, By Labeling Type (2016-2030)
12.2.3. Market Revenue and Forecast, By Method (2016-2030)
12.2.4. Market Revenue and Forecast, By Application (2016-2030)
12.2.5. Market Revenue and Forecast, By Sector (2016-2030)
12.2.6. UK
12.2.6.1. Market Revenue and Forecast, By Product Type (2016-2030)
12.2.6.2. Market Revenue and Forecast, By Labeling Type (2016-2030)
12.2.6.3. Market Revenue and Forecast, By Method (2016-2030)
12.2.7. Market Revenue and Forecast, By Application (2016-2030)
12.2.8. Market Revenue and Forecast, By Sector (2016-2030)
12.2.9. Germany
12.2.9.1. Market Revenue and Forecast, By Product Type (2016-2030)
12.2.9.2. Market Revenue and Forecast, By Labeling Type (2016-2030)
12.2.9.3. Market Revenue and Forecast, By Method (2016-2030)
12.2.10. Market Revenue and Forecast, By Application (2016-2030)
12.2.11. Market Revenue and Forecast, By Sector (2016-2030)
12.2.12. France
12.2.12.1. Market Revenue and Forecast, By Product Type (2016-2030)
12.2.12.2. Market Revenue and Forecast, By Labeling Type (2016-2030)
12.2.12.3. Market Revenue and Forecast, By Method (2016-2030)
12.2.12.4. Market Revenue and Forecast, By Application (2016-2030)
12.2.13. Market Revenue and Forecast, By Sector (2016-2030)
12.2.14. Rest of Europe
12.2.14.1. Market Revenue and Forecast, By Product Type (2016-2030)
12.2.14.2. Market Revenue and Forecast, By Labeling Type (2016-2030)
12.2.14.3. Market Revenue and Forecast, By Method (2016-2030)
12.2.14.4. Market Revenue and Forecast, By Application (2016-2030)
12.2.15. Market Revenue and Forecast, By Sector (2016-2030)
12.3. APAC
12.3.1. Market Revenue and Forecast, By Product Type (2016-2030)
12.3.2. Market Revenue and Forecast, By Labeling Type (2016-2030)
12.3.3. Market Revenue and Forecast, By Method (2016-2030)
12.3.4. Market Revenue and Forecast, By Application (2016-2030)
12.3.5. Market Revenue and Forecast, By Sector (2016-2030)
12.3.6. India
12.3.6.1. Market Revenue and Forecast, By Product Type (2016-2030)
12.3.6.2. Market Revenue and Forecast, By Labeling Type (2016-2030)
12.3.6.3. Market Revenue and Forecast, By Method (2016-2030)
12.3.6.4. Market Revenue and Forecast, By Application (2016-2030)
12.3.7. Market Revenue and Forecast, By Sector (2016-2030)
12.3.8. China
12.3.8.1. Market Revenue and Forecast, By Product Type (2016-2030)
12.3.8.2. Market Revenue and Forecast, By Labeling Type (2016-2030)
12.3.8.3. Market Revenue and Forecast, By Method (2016-2030)
12.3.8.4. Market Revenue and Forecast, By Application (2016-2030)
12.3.9. Market Revenue and Forecast, By Sector (2016-2030)
12.3.10. Japan
12.3.10.1. Market Revenue and Forecast, By Product Type (2016-2030)
12.3.10.2. Market Revenue and Forecast, By Labeling Type (2016-2030)
12.3.10.3. Market Revenue and Forecast, By Method (2016-2030)
12.3.10.4. Market Revenue and Forecast, By Application (2016-2030)
12.3.10.5. Market Revenue and Forecast, By Sector (2016-2030)
12.3.11. Rest of APAC
12.3.11.1. Market Revenue and Forecast, By Product Type (2016-2030)
12.3.11.2. Market Revenue and Forecast, By Labeling Type (2016-2030)
12.3.11.3. Market Revenue and Forecast, By Method (2016-2030)
12.3.11.4. Market Revenue and Forecast, By Application (2016-2030)
12.3.11.5. Market Revenue and Forecast, By Sector (2016-2030)
12.4. MEA
12.4.1. Market Revenue and Forecast, By Product Type (2016-2030)
12.4.2. Market Revenue and Forecast, By Labeling Type (2016-2030)
12.4.3. Market Revenue and Forecast, By Method (2016-2030)
12.4.4. Market Revenue and Forecast, By Application (2016-2030)
12.4.5. Market Revenue and Forecast, By Sector (2016-2030)
12.4.6. GCC
12.4.6.1. Market Revenue and Forecast, By Product Type (2016-2030)
12.4.6.2. Market Revenue and Forecast, By Labeling Type (2016-2030)
12.4.6.3. Market Revenue and Forecast, By Method (2016-2030)
12.4.6.4. Market Revenue and Forecast, By Application (2016-2030)
12.4.7. Market Revenue and Forecast, By Sector (2016-2030)
12.4.8. North Africa
12.4.8.1. Market Revenue and Forecast, By Product Type (2016-2030)
12.4.8.2. Market Revenue and Forecast, By Labeling Type (2016-2030)
12.4.8.3. Market Revenue and Forecast, By Method (2016-2030)
12.4.8.4. Market Revenue and Forecast, By Application (2016-2030)
12.4.9. Market Revenue and Forecast, By Sector (2016-2030)
12.4.10. South Africa
12.4.10.1. Market Revenue and Forecast, By Product Type (2016-2030)
12.4.10.2. Market Revenue and Forecast, By Labeling Type (2016-2030)
12.4.10.3. Market Revenue and Forecast, By Method (2016-2030)
12.4.10.4. Market Revenue and Forecast, By Application (2016-2030)
12.4.10.5. Market Revenue and Forecast, By Sector (2016-2030)
12.4.11. Rest of MEA
12.4.11.1. Market Revenue and Forecast, By Product Type (2016-2030)
12.4.11.2. Market Revenue and Forecast, By Labeling Type (2016-2030)
12.4.11.3. Market Revenue and Forecast, By Method (2016-2030)
12.4.11.4. Market Revenue and Forecast, By Application (2016-2030)
12.4.11.5. Market Revenue and Forecast, By Sector (2016-2030)
12.5. Latin America
12.5.1. Market Revenue and Forecast, By Product Type (2016-2030)
12.5.2. Market Revenue and Forecast, By Labeling Type (2016-2030)
12.5.3. Market Revenue and Forecast, By Method (2016-2030)
12.5.4. Market Revenue and Forecast, By Application (2016-2030)
12.5.5. Market Revenue and Forecast, By Sector (2016-2030)
12.5.6. Brazil
12.5.6.1. Market Revenue and Forecast, By Product Type (2016-2030)
12.5.6.2. Market Revenue and Forecast, By Labeling Type (2016-2030)
12.5.6.3. Market Revenue and Forecast, By Method (2016-2030)
12.5.6.4. Market Revenue and Forecast, By Application (2016-2030)
12.5.7. Market Revenue and Forecast, By Sector (2016-2030)
12.5.8. Rest of LATAM
12.5.8.1. Market Revenue and Forecast, By Product Type (2016-2030)
12.5.8.2. Market Revenue and Forecast, By Labeling Type (2016-2030)
12.5.8.3. Market Revenue and Forecast, By Method (2016-2030)
12.5.8.4. Market Revenue and Forecast, By Application (2016-2030)
12.5.8.5. Market Revenue and Forecast, By Sector (2016-2030)
Chapter 13. Company Profiles
13.1. PerkinElmer, Inc.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. F. Hoffmann La-Roche AG
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. General Electric Healthcare Life Sciences
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Thermo Fisher Scientific Inc.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Promega Corporation
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. New England Biolabs
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Enzo Biochem, Inc.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Vector Laboratories Inc.
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Merck KGaA.
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Agilent Technologies
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
Glossary of Terms